Otolaryngology Doctors in Chandler, AZ Accepting Medicare

5 Otolaryngology doctors found. Showing 1 - 5

Curt A Allison, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2081 W Frye Rd Ste 100, Chandler, AZ 85224 Phone: 480-753-1459    Fax: 480-753-5311

Michael J. Fucci, M.D. Otolaryngology - Otology & Neurotology Medicare: Accepting Medicare Assignments Practice Location: 225 S. Dobson Rd., Chandler, AZ 85224 Phone: 480-558-5306    Fax: 480-558-5307

Adam Cassis, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 225 S Dobson Rd, Chandler, AZ 85224 Phone: 480-558-5306    Fax: 480-558-5307

Dr. Maulik B Shah, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2151 E Pecos Rd Ste 1, Chandler, AZ 85225 Phone: 480-676-3322    Fax: 480-676-3523

Dr. Homan Mostafavi, D.O. Otolaryngology - Otolaryngology/Facial Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2051 W Chandler Blvd Ste 5, Chandler, AZ 85224 Phone: 480-214-9000    Fax: 480-214-9999

News Archive

Bioalliance Pharma's anti-emetic drug Setofilm receives European approval

BioAlliance Pharma SA, a company dedicated to the treatment and supportive care of cancer and AIDS patients, today announced approval for Setofilm® in 16 European countries.

Immunologist focuses on initial stages of infection to fight against HIV

In a project funded by the Austrian Science Fund FWF, Doris Wilflingseder investigates the initial stages of infection - the time span when the immune system might still stop HIV.

Congress should maintain support of global health programs 'despite fiscal challenges'

"U.S. support for global health has had a major impact around the world, particularly our contributions to fighting malaria through the President's Malaria Initiative and the Global Fund to Fight AIDS, Tuberculosis, and Malaria," Rep. Ander Crenshaw (R-Fla.), co-chair of the Congressional Caucus on Malaria and Neglected Tropical Diseases, and Steve Davis, CEO of PATH, write in a Washington Times opinion piece.

EUSA completes BLA filing for ERWINASE in treatment of acute lymphoblastic leukemia

EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, oncology supportive care and critical care, today announced that it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for ERWINASE(R) (L-asparaginase derived from Erwinia chrysanthemi) for use in the treatment of acute lymphoblastic leukemia in patients with hypersensitivity to E. coli-derived asparaginase.

Read more Medical News

› Verified 8 days ago